REP. MICHAEL BURGESS (R-TX) received the American Society of Clinical Oncology‘s first-ever ASCO Congressional Leadership Award for his work to support policies related to cancer research and treatment. The new, annual award honors a member of Congress who is a consistent champion for patients and survivors of cancer, their families, and health care teams. Burgess...
More than a year after a catastrophic shortage of platinum-based chemotherapy drugs swept through the U.S., FDA on June 28 officially removed carboplatin and cisplatin from the drug shortage list.
